NCT04358081 - Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

July 27, 2020

Study Completion Date

July 27, 2020

Conditions

Covid-19

Interventions

DRUG

HCQ

Hydroxychloroquine Monotherapy

DRUG

HCQ+AZT

Hydroxychloroquine with azithromycin

DRUG

Placebo

Trial Locations (7)

Novartis Investigative Site, Baltimore

Novartis Investigative Site, Chapel Hill

Novartis Investigative Site, Chicago

Novartis Investigative Site, Baton Rouge

Novartis Investigative Site, Fullerton

Novartis Investigative Site, Seattle

Novartis Investigative Site, Los Angeles